CapsoVision (CV) Common Equity (2024 - 2026)
CapsoVision (CV) posted Common Equity of $13.3 million for Q4 2025, down 35.13% sequentially from $20.4 million in Q3 2025, and up 110.24% YoY from $6.3 million in Q4 2024.
CapsoVision (CV) Common Equity (2024 - 2026) Analysis & Trends
CapsoVision has reported Common Equity for 2 years, with the latest figure at $13.3 million in Q4 2025.
- Quarterly Common Equity rose 110.24% year-over-year to $13.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.3 million (up 110.24% YoY) and the FY2025 annual result came in at $13.3 million, up 110.24% from the prior year.
- Common Equity slipped to $13.3 million in Q4 2025 per CV's latest filing, from $20.4 million in the prior quarter.
- Over five years, Common Equity peaked at $20.4 million in Q3 2025 and troughed at -$139.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | CapsoVision | 295.13 Mn | 286.05 Mn | 1.87 Mn | 13.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.17 Mn |
| Dec 31, 2025 | 13.26 Mn |
| Sep 30, 2025 | 20.44 Mn |
| Jun 30, 2025 | -138.99 Mn |
| Dec 31, 2024 | -129.51 Mn |
| Sep 30, 2024 | -124.99 Mn |
| Jun 30, 2024 | -119.21 Mn |